Abstract
A series of novel β-chloro vinyl chalcones have been synthesized from substituted (Z) – 3 – chloro – 3- phenylacraldehydes with 1-(3 – bromo – 2 – hydroxyl-4,6- dimethoxyphenyl)ethanone by Claisen-Schmidt condensation reaction. Compounds were screened for anti-inflammatory, anticancer and antioxidant activity. Compounds 6a, 6d and 6f revealed promising anti-inflammatory activity (87 – 99 %) with less cytotoxicity (4 – 9 %) at 10 µ M. Compounds 6a, 6d, 6e and 6f having significant anticancer activity (71 – 83 %). Bioavailability of compounds were checked by in vitro cytotoxicity and confirmed to be nontoxic. Structure activity relationship and in silico drug relevant properties of compounds revealed as potential candidates for future drug discovery study.
Keywords: Anti-inflammatory activity, Anticancer activity, Antioxidant activity, In silico, luekotrienes, Claisen-Schmidt condensation reaction, Reactive oxygen species (ROS), cytotoxicity, Bioavailability, cytokines, TNF-α, atherosclerosis, rheumatoid arthritis (RA), haematopoiesis
Letters in Drug Design & Discovery
Title: Synthesis, Biological Evaluation and In Silico Study of β-Chloro Vinyl Chalcones as Inhibitors of the TNF-α, IL-6 With Anticancer and Antioxidant Activity
Volume: 8 Issue: 8
Author(s): Babasaheb P. Bandgar, Baliram S. Hote and Shivraj H Nile
Affiliation:
Keywords: Anti-inflammatory activity, Anticancer activity, Antioxidant activity, In silico, luekotrienes, Claisen-Schmidt condensation reaction, Reactive oxygen species (ROS), cytotoxicity, Bioavailability, cytokines, TNF-α, atherosclerosis, rheumatoid arthritis (RA), haematopoiesis
Abstract: A series of novel β-chloro vinyl chalcones have been synthesized from substituted (Z) – 3 – chloro – 3- phenylacraldehydes with 1-(3 – bromo – 2 – hydroxyl-4,6- dimethoxyphenyl)ethanone by Claisen-Schmidt condensation reaction. Compounds were screened for anti-inflammatory, anticancer and antioxidant activity. Compounds 6a, 6d and 6f revealed promising anti-inflammatory activity (87 – 99 %) with less cytotoxicity (4 – 9 %) at 10 µ M. Compounds 6a, 6d, 6e and 6f having significant anticancer activity (71 – 83 %). Bioavailability of compounds were checked by in vitro cytotoxicity and confirmed to be nontoxic. Structure activity relationship and in silico drug relevant properties of compounds revealed as potential candidates for future drug discovery study.
Export Options
About this article
Cite this article as:
P. Bandgar Babasaheb, S. Hote Baliram and Nile Shivraj H, Synthesis, Biological Evaluation and In Silico Study of β-Chloro Vinyl Chalcones as Inhibitors of the TNF-α, IL-6 With Anticancer and Antioxidant Activity, Letters in Drug Design & Discovery 2011; 8 (8) . https://dx.doi.org/10.2174/157018011796576051
DOI https://dx.doi.org/10.2174/157018011796576051 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Molecular Mechanisms and Therapeutic Application of NSAIDs and Derived Compounds in Alzheimers Disease
Current Alzheimer Research Molecular and Cellular Regulators of Cancer Angiogenesis
Current Cancer Drug Targets The Link Between Conventional and Novel Anti-Cancer Therapeutics with Thrombotic Microangiopathy
Drug Metabolism Letters Hepcidin in Iron Metabolism
Current Protein & Peptide Science Heterocyclic Drug-polymer Conjugates for Cancer Targeted Drug Delivery
Anti-Cancer Agents in Medicinal Chemistry Nanomedicine: Magnetic Nanoparticles and their Biomedical Applications
Current Medicinal Chemistry Paclitaxel Nanoparticles Induce Apoptosis and Regulate TXR1, CYP3A4 and CYP2C8 in Breast Cancer and Hepatoma Cells
Anti-Cancer Agents in Medicinal Chemistry Chemokines and Their Receptors: Potential Therapeutic Targets for Bone Cancer Pain
Current Pharmaceutical Design Current Guidelines and Strategies in Management of Renal Vein Thrombosis
Current Pediatric Reviews Na+-H+ Exchanger, pH Regulation and Cancer
Recent Patents on Anti-Cancer Drug Discovery Involvement of Cysteine Proteases in Cancer
Current Medicinal Chemistry Targeting Heat Shock Protein 90 for Malaria
Mini-Reviews in Medicinal Chemistry Integrated Genomic and Pharmacological Approaches to Identify Synthetic Lethal Genes as Cancer Therapeutic Targets
Current Molecular Medicine Approaches for Imaging the Diabetic Pancreas: First Results
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Bisphosphonates and Breast Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Histopathological Determinants of Tumor Resistance: A Special Look to the Immunohistochemical Expression of Carbonic Anhydrase IX in Human Cancers
Current Medicinal Chemistry Recent Developments of Platinum-based Anticancer Drugs- Detection and Analysis in Biological Samples
Current Organic Chemistry Protease-Activated Receptor-2 Antagonists and Agonists
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Hsp90: A Novel Target for Cancer Therapy
Current Topics in Medicinal Chemistry Reactive Oxygen Species: Physiological Roles in the Regulation of Vascular Cells
Current Molecular Medicine